CLINICAL WHITE PAPER
Radiosurgery has become the first-line treatment option for patients with multiple brain metastases, prolonging overall survival for younger patients when salvage treatment options are readily available. Treatment decisions are no longer based on the number of metastases but rather on the cumulative tumor volume, with hypo-fractionated radiosurgery regimens a viable alternative for patients with large disease burden.
Traditional radiosurgical approaches target each metastasis individually; prioritizing superior dose gradients over treatment efficiency as the total treatment time scales linearly with the number of metastases. By targeting up to ten metastases at once, Brainlab Automatic Brain Metastases Planning optimizes treatments both in terms of plan quality and delivery efficiency.